Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Dynoodt

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2021
Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factorsSeodhna M Lynch, Niamh M Russell, Stephen Barron, et al.
Oncotarget|May 11, 2017
Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancerLinda Zuurbier, Arman Rahman, Martijn Cordes, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2021
Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factorsSeodhna M Lynch, Niamh M Russell, Stephen Barron, et al.
Oncotarget|May 11, 2017
Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancerLinda Zuurbier, Arman Rahman, Martijn Cordes, et al.
Pageof 2